MTF Biologics
-
Biologics
MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advance Wound Care Technologies
Organizations build on existing relationship, forging new agreement aimed at growing distribution of wound care innovations in acute care and…
Read More » -
Biologics
Kolosis BIO and MTF Biologics Forge Strategic Partnership to Enter Surgical Incision Market
Salt Lake City, Utah, May 31, 2023/OrthoSpineNews/ – Kolosis BIO (Kolosis), a leading provider of biologics solutions, and MTF Biologics, a…
Read More » -
Biologics
MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft
Innovative allograft offers new treatment option for diabetic foot ulcers and venous leg ulcers EDISON, N.J., April 17, 2023–(BUSINESS WIRE) —MTF…
Read More » -
Biologics
Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration
PRINCETON, N.J., March 16, 2023 /PRNewswire/ — Geistlich Pharma North America Inc. is pleased to introduce a growing variety of vallos® allograft configurations…
Read More » -
Biologics
Kolosis BIO and MTF Biologics Extend Exclusive Agreement
SALT LAKE CITY, Utah, February 14, 2023/OrthoSpineNews/ – Kolosis BIO (Kolosis), a leading provider of orthobiologics solutions, and MTF Biologics, a…
Read More » -
Extremities
Orthofix Announces First Patient Implants with Legacy Demineralized Bone Matrix for Spine, Pelvic and Extremities Procedures
LEWISVILLE, TEXAS – October 13, 2022 – OrthoSpineNews – Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine…
Read More » -
Biologics
Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS — October 12, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Biologics
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS – July 26, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Biologics
Orthofix and MTF Biologics Expand Partnership Agreement
May 3, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix
Secures rhNELL-1 Carrier for Bone Regeneration Spine Fusion Product March 7, 2022 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer…
Read More » -
Biologics
MTF Biologics Awards More Than $1 Million in 2021 Research Grants to Support Allograft Research
Non-profit organization now accepting applications for 2022 grants to accelerate innovation in tissue transplantation February 9, 2022 EDISON, N.J.–(BUSINESS WIRE)–MTF…
Read More » -
Biologics
Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™
February 17, 2021 SALT LAKE CITY–(BUSINESS WIRE)–Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market…
Read More » -
Biologics
Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
June 06, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF…
Read More » -
Biologics
BONESUPPORT Signs Agreement with MTF Biologics to Expand US Product Offering
Lund, Sweden, 08:00am CET, 2 August 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids,…
Read More »